PF-Atlas › Clinical Trials › NCT02673021
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor
Microwave ablation · Not specified
Registry ID
NCT02673021
Phase
Not specified
Status
Terminated
Drug / intervention
Microwave ablation
Sponsor
Mayo Clinic
Start
2016-06-08
About this trial
Microwave ablation is evaluated in NCT02673021, a idiopathic pulmonary fibrosis study sponsored by Mayo Clinic. Current status: Terminated.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT02673021 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.